Canada - English - Health Canada

pharmascience inc - zopiclone - tablet - 3.75mg - zopiclone 3.75mg - miscellaneous anxiolytics sedatives and hypnotics

United States - English - NLM (National Library of Medicine)

a-s medication solutions - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - eszopiclone tablet is indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). eszopiclone is contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)]. pregnancy category c there are no adequate and well-controlled studies in pregnant women. eszopiclone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of eszopiclone to pregnant rats (62.5, 125, or 250 mg/kg/day) and rabbits (4, 8, or

United States - English - NLM (National Library of Medicine)

a-s medication solutions - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - eszopiclone tablets are indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6 week study (adults only), at the end of both 2 week studies (elderly only) and at the end of the 6 month study (adults only). eszopiclone tablets are contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3) ]. there are no adequate and well-controlled studies in pregnant women. eszopiclone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of eszopiclone to pregnant rats (62.5, 125, or 250 mg/kg/day) and rabbits (4, 8, or 16 mg/kg

Canada - English - Health Canada

dominion pharmacal - zopiclone - tablet - 7.5mg - zopiclone 7.5mg - miscellaneous anxiolytics sedatives and hypnotics

Canada - English - Health Canada

dominion pharmacal - zopiclone - tablet - 5mg - zopiclone 5mg - miscellaneous anxiolytics sedatives and hypnotics

Canada - English - Health Canada

jamp pharma corporation - zopiclone - tablet - 5mg - zopiclone 5mg - miscellaneous anxiolytics sedatives and hypnotics

Canada - English - Health Canada

jamp pharma corporation - zopiclone - tablet - 7.5mg - zopiclone 7.5mg - miscellaneous anxiolytics sedatives and hypnotics

Canada - English - Health Canada

marcan pharmaceuticals inc - zopiclone - tablet - 5mg - zopiclone 5mg - miscellaneous anxiolytics sedatives and hypnotics

Canada - English - Health Canada

marcan pharmaceuticals inc - zopiclone - tablet - 7.5mg - zopiclone 7.5mg - miscellaneous anxiolytics sedatives and hypnotics

Canada - English - Health Canada

marcan pharmaceuticals inc - zopiclone - tablet - 5mg - zopiclone 5mg - miscellaneous anxiolytics sedatives and hypnotics